United Services Automobile Association reduced its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 23.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 93,168 shares of the medical instruments supplier’s stock after selling 28,311 shares during the period. United Services Automobile Association’s holdings in Becton, Dickinson and were worth $17,091,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in BDX. Dodge & Cox acquired a new stake in shares of Becton, Dickinson and during the fourth quarter valued at about $2,290,000. Quadrature Capital Ltd acquired a new stake in shares of Becton, Dickinson and during the fourth quarter valued at about $944,000. UBS Asset Management Americas Inc. increased its stake in shares of Becton, Dickinson and by 6.1% in the fourth quarter. UBS Asset Management Americas Inc. now owns 802,950 shares of the medical instruments supplier’s stock valued at $132,928,000 after buying an additional 46,415 shares during the period. Teachers Advisors LLC increased its stake in shares of Becton, Dickinson and by 1.8% in the fourth quarter. Teachers Advisors LLC now owns 346,573 shares of the medical instruments supplier’s stock valued at $57,375,000 after buying an additional 5,995 shares during the period. Finally, Kentucky Retirement Systems acquired a new stake in shares of Becton, Dickinson and during the fourth quarter valued at about $2,551,000. 75.42% of the stock is currently owned by institutional investors.
Becton, Dickinson and Company (NYSE:BDX) opened at 202.02 on Thursday. Becton, Dickinson and Company has a 12 month low of $161.29 and a 12 month high of $202.57. The company’s 50-day moving average is $194.81 and its 200 day moving average is $184.31. The firm has a market cap of $43.09 billion, a price-to-earnings ratio of 33.55 and a beta of 1.05.
Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings results on Tuesday, May 2nd. The medical instruments supplier reported $2.30 EPS for the quarter, topping the consensus estimate of $2.23 by $0.07. The business had revenue of $2.97 billion during the quarter, compared to analysts’ expectations of $2.92 billion. Becton, Dickinson and had a net margin of 10.67% and a return on equity of 25.37%. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period last year, the company posted $2.18 earnings per share. On average, equities research analysts predict that Becton, Dickinson and Company will post $9.45 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, June 30th. Investors of record on Friday, June 9th were issued a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a dividend yield of 1.45%. The ex-dividend date was Wednesday, June 7th. Becton, Dickinson and’s dividend payout ratio is currently 48.26%.
TRADEMARK VIOLATION NOTICE: This article was first published by Stock Observer and is owned by of Stock Observer. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.thestockobserver.com/2017/07/20/united-services-automobile-association-sells-28311-shares-of-becton-dickinson-and-company-bdx.html.
BDX has been the topic of several recent research reports. Jefferies Group LLC reaffirmed a “buy” rating and issued a $200.00 price target on shares of Becton, Dickinson and in a report on Wednesday, March 29th. Zacks Investment Research raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $206.00 price objective on the stock in a research note on Tuesday, April 11th. Royal Bank Of Canada reissued a “hold” rating and set a $177.00 price objective on shares of Becton, Dickinson and in a research note on Thursday, April 13th. Evercore ISI raised shares of Becton, Dickinson and from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $186.00 to $200.00 in a research note on Monday, April 24th. Finally, Raymond James Financial, Inc. raised shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and reduced their price objective for the company from $210.00 to $180.00 in a research note on Friday, June 30th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $192.17.
In related news, VP Jeffrey S. Sherman sold 28,765 shares of the firm’s stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the completion of the sale, the vice president now directly owns 70,821 shares in the company, valued at $13,171,289.58. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.40% of the company’s stock.
About Becton, Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Company and related companies with MarketBeat.com’s FREE daily email newsletter.